Start Date: Apr 08, 2006
End Date: Apr 07, 2011
The goal of Objective 1 will be to characterize the maturing cellular and humoral (i.e., antibody-specific) immune responses of calves elicited by neonatal vaccination with standard and newer DNA-based vaccines, and correlate these responses with the degree of protection afforded against subsequent experimental infection several months after weaning. The goal of Objective 2 will be to evaluate the effects of growth rate, cold stress, and vitamins A and D as supplements or adjuvants on immune function, health and growth performance of neonatal calves. The goal of Objective 3 will be to evaluate the effects of enhanced dietary protein and energy, provided in the form of an intensified milk replacer, on the health and growth performance of preweaned calves in a "real world" commercial setting where disease exposure is typical of that found on calf-rearing farms. IBC-0317 - BSL-2, Approved 11/17/09.